Press Releases on January 9, 2023 - EIN Presswire - Press Release Distribution Service

Published on January 9, 2023 - 13:00 GMT

Theriva Biologics Announces Dosing of First Patient in the Investigator Sponsored Phase 1 Trial of VCN-01, an Intravenous ...

-Clinical trial is being conducted at St. James’s University Hospital, United Kingdom, in collaboration with the University of Leeds- ROCKVILLE, Md., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), …

Distribution channels: Science, Technology ...

Published on January 9, 2023 - 13:00 GMT

Alimera Sciences Appoints Industry Veteran Russell L. Skibsted as Chief Financial Officer

ATLANTA, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better …

Distribution channels:

Published on January 9, 2023 - 13:00 GMT

Daré Bioscience Announces Positive Pharmacokinetic (PK) Results from the DARE-HRT1 Phase 1 / 2 Study that Support the Potential of ...

Daré Plans to Advance DARE-HRT1 into Single Phase 3 Efficacy Trial for Treatment of Vasomotor Symptoms (VMS) due to Menopause DARE-HRT1 has the potential to be the first FDA-approved monthly intravaginal ring delivering both estrogen and progestogen …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on January 9, 2023 - 13:00 GMT

Jellyvision Acquires Picwell to Power Highly Personalized Employee Benefits Experiences

CHICAGO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Jellyvision, the company behind ALEX®, the leading employee benefits engagement technology, announced it has acquired Picwell, a healthcare technology company focused on AI-generated benefits decision support. …

Distribution channels:

Published on January 9, 2023 - 13:00 GMT

iPower Unveils New Brand Identity

DUARTE, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- iPower Inc. (Nasdaq:IPW) (“iPower” or the “Company”), a leading online retailer and supplier of consumer home and garden products, today announced the completion of an extensive corporate rebrand and new …

Distribution channels: Culture, Society & Lifestyle, IT Industry ...

Published on January 9, 2023 - 13:00 GMT

STRATA Skin Sciences Expands into $300 Million Market with Exclusive Distribution Agreement in Mexico

HORSHAM, Pa., Jan. 09, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 9, 2023 - 13:00 GMT

PROCEPT BioRobotics Announces Preliminary Fourth Quarter and Fiscal Year 2022 Revenue

REDWOOD CITY, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on January 9, 2023 - 13:00 GMT

Achieve Life Sciences Announces Last Subject Dosed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation

SEATTLE, Wash and VANCOUVER, British Columbia, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 9, 2023 - 13:00 GMT

Krystal Biotech Announces FDA’s 3-Month Extension of BLA PDUFA Date and Regulatory Update for B-VEC to Treat Patients with ...

PITTSBURGH, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that on January 5, 2023, the U.S. Food and Drug Administration (FDA) notified the Company that based on manufacturing information submitted …

Distribution channels: Media, Advertising & PR, Science ...

Published on January 9, 2023 - 13:00 GMT

Global Crossing Airlines Announces Glen Gates as Vice President - A321 Freighter Programs

MIAMI, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Global Crossing Airlines Group, Inc. (JET: NEO; JET.B: NEO; JETMF: OTCQB) (the “Company” or “GlobalX”) is pleased to announce the appointment of Mr. Glen Gates as Vice President - A321 Freighter Programs. Mr. Gates …

Distribution channels: Shipping, Storage & Logistics ...

Published on January 9, 2023 - 13:00 GMT

Selecta Biosciences Provides Business Update and Outlook for 2023

- Expected topline data for Phase 3 DISSOLVE I & II programs of SEL-212 in chronic refractory gout in Q1 2023 - - To receive $10 million upfront for the execution of a license agreement for Xork, the Company’s next-generation immunoglobulin G (IgG) …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 9, 2023 - 13:00 GMT

Quantum Energy Partners Expands Leadership Team

Michael MacDougall Joins as Partner With a Focus on Energy Transition and Decarbonization John Shearburn Joins as Senior Advisor With a Focus on Fundraising and Investor Relations Mike Denham, Jonathan Regan and Blake Webster Promoted to Partner HOUSTON, …

Distribution channels: Companies, Energy Industry ...

Published on January 9, 2023 - 13:00 GMT

Xtant Medical Appoints Mark Schallenberger as Chief Operations Officer

BELGRADE, Mont., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the appointment of Mark …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on January 9, 2023 - 13:00 GMT

TFF Pharmaceuticals Announces the Appointment of Zamaneh Mikhak, M.D. as Chief Medical Officer

FORT WORTH, Texas, Jan. 09, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing technology …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on January 9, 2023 - 13:00 GMT

Hepion Pharmaceuticals Receives $3.2 Million in Aggregate Non-Dilutive Funding

EDISON, N.J., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of fibrotic diseases, …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on January 9, 2023 - 13:00 GMT

Toymint to Launch its Next Generation of Minted Teddy Metaverse Toys

Vancouver, B.C., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Toymint, a web3 toy company on a mission to build a better world by creating high-quality, sustainable children's toys, is announcing that it is releasing its next generation of Minted Teddy NFTs and …

Distribution channels: Gifts, Games & Hobbies, Media, Advertising & PR ...

Published on January 9, 2023 - 13:00 GMT

Surge Copper Identifies New Copper-Gold Porphyry Potential 300 metres Northeast of the East Seel Deposit Intersecting 100 metres ...

Vancouver, British Columbia, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV: SURG) (OTCQX: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) is pleased to announce complete assay results for 3 holes from the Company’s 100% owned Ootsa …

Distribution channels:

Published on January 9, 2023 - 13:00 GMT

BrewBilt Brewing: Beer Pairings, Increased Sales, More Large Retailers, $130M Partnership

GRASS VALLEY, CA, Jan. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Today BrewBilt Brewing Company (the "Company") (OTCPINK: BRBL) announced that the Company continues to thrive in the craft beer industry, out-performing growth trends and …

Distribution channels: Companies, Food & Beverage Industry ...

Published on January 9, 2023 - 13:00 GMT

Imbria Enrolls First Patient in the Phase 2 IMPROVE-DiCE Clinical Trial Evaluating Ninerafaxstat in Patients with Heart Failure ...

BOSTON, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company developing novel therapies designed to enhance cellular energetics, today announced the enrollment of the first patient in Part 2 of the …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 9, 2023 - 13:00 GMT

Vaccinex Announces First Patient Dosed with Anti-CCR8 Antibody Licensed to Surface Oncology

ROCHESTER, N.Y., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative disease through the inhibition of SEMA4D, today announced …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...